The study results, according to the authors, suggest that the combination of folinic acid plus the chemotherapies fluorouracil and oxaliplatin should become the standard-of-care therapy in patients with advanced biliary tract cancer whose disease progressed with cisplatin and gemcitabine.
The effectiveness of the Pfizer-BioNTech COVID-19 vaccine increased significantly among patients with cancer who received a vaccine booster 21 days after receiving the first dose.
“Summer finds many of us outdoors and during that time, it’s important to protect our skin from the dangerous rays of the sun,” writes one breast cancer survivor. Learn more about how to use sunscreen, protect your skin and avoid skin cancer.
Adolescent and young adult cancer survivors were more likely to misuse substances including drugs and alcohol compared with their peers without a history of cancer, which may be a result of overprescribing from doctors or inefficient pain management.
Researchers have developed Myeloma Drug Sensitivity Testing to determine which medications will be most effective with minimal side-effects.
This maintenance therapy approach approved progression-free survival without a major impact on quality of life in patients with newly diagnosed ovarian cancer with a BRCA mutation who recently responded to chemotherapy.
Some of the most popular YouTube videos about bladder cancer are of poor quality, spread misinformation and have commercial bias.
A woman with metastatic breast cancer shares a story about a woman with the same diagnosis and a recipe that was distantly inspired by their conversation.
In an accompanying editorial to the recently updated U.S. Preventive Services Task Force recommendation for colorectal cancer screenings, doctors suggested additional measures that would help increase the screening rate among eligible adults and potentially lower the mortality rate.
Vulnerable older patients with advanced ovarian cancer do not respond well to carboplatin treatment alone compared to a combination with paclitaxel.
Scientists have identified a potentially valuable genetic target in children with acute myeloid leukemia that could lead to further studies in immunotherapy drugs for the disease.
On social media, CURE® recently asked its readers to share what unexpected, non-treatment-related costs they incurred during their cancer journey. Here’s what they shared.
A retirement counselor with bladder cancer shares the story of his diagnosis and his thoughts on treatment.
Factors such as race, smoking, longer survival time and treatment may affect the voice and speech production of survivors of oropharyngeal cancer.
A fellow nurse describes how her colleague is a healing presence to not only her patients but also the clinical team.
A survivor of multiple cancers over the span of 27 years expresses her feelings about her cancer journey through a poem.
A nurse practitioner strives to provide tailored care to children with cancer and their families when they are receiving treatment and supportive services.
A cancer survivor explains how she finds time to be productive while dealing with exhaustion.
A doctor describes a nurse’s ability to make his job rewarding and efficient, which he said can be a rare quality in a partner.
A colleague describes a nurse’s aim to not only provide the best care for her patients but also be a continuous student of health care.
The study results lend strength to discuss prostate cancer screening in younger Black men, according to an expert.
The decision from the Food and Drug Administration marks the first approval of a targeted treatment option for adults with non-small cell lung cancer whose tumors harbor a specific genetic mutation.
A caregiver describes her daughter’s experience with breast cancer, and what the month of May signifies to them both.
From Al Roker’s cancer screening advice to the death of actor Charles Grodin, here’s what’s happening in the cancer landscape this week.
The data, according to an expert, show that treatment with Tecentriq could delay disease progression to an advanced stage, as well as the need for more aggressive therapy.
The use of Opdivo combined with the novel therapy relatlimab resulted in a significant improvement of progression-free survival compared to treatment with Opdivo, alone, in patients with previously untreated, unresectable or metastatic melanoma.
Opdivo was approved by the FDA for use if disease persisted after neoadjuvant chemoradiotherapy in these patients, which is “exciting news,” as patients would typically undergo surveillance when this occurred.
Almost 20 years of data indicate that the incidence of HPV-related cervical cancer is noticeably declining, however other cancers related to the virus continue, and are expected, to increase.
A patient offers advice on getting patient portals, electronic medical records and technology organized and functioning correctly.
In this episode of the “CURE® Talks Cancer” podcast, Dr. William Breitbart, chairman of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center, discusses the impact of the COVID-19 pandemic on mental health within the cancer community and what people can do to manage this extra strain.
